The positive-strand RNA virus known as hepatitis C virus (HCV) belongs to the family Flaviviridae's genus Hepacivirus. At least six genotypes (gt) of HCV exist, and the polymerase's error-prone nature results in more than 50 subtypes. The host and viral proteases break down the long open reading frame, which encodes the HCV polyprotein, into seven nonstructural (NS) proteins (p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B) and three structural proteins (the capsid protein core and envelope glycoproteins E1 and E2). While NS3 to NS5B are involved in a membrane-associated RNA replicase complex (RC), NS2 and p7 are required for virus assembly but not RNA replication.NS4A acts as a cofactor for the NS3 serine protease, NS5B is the RNA-dependent RNA polymerase, and NS5A is thought to play important roles in numerous stages of the HCV life cycle. The NS3 protein is made up of a serine protease and an RNA helicase/nucleoside triphosphatase (NTPase).After being administered to HCV-infected cells, NS5A inhibitors quickly reduce the virus' ability to infect cells.
By preventing Kv2.1 function and preventing apoptosis, the HCV protein NS5A prevents the loss of intracellular potassium that would otherwise occur in hepatocytes.
Alpha interferon, Telaprevir, the NS5A inhibitor BMS-790052, and PSI-7977, as well as the combination of lucidone and alpha interferon, all work synergistically to inhibit HCV RNA replication.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V17776 | MK-0608 | 443642-29-3 | MK-0608 (MK608; 7-deaza-2'-C-methyladenosine; 7-DMA. |
|
V53281 | Monodes(N-carboxymethyl)valine Daclatasvir (Daclatasvir Impurity A) | 1007884-60-7 | Monodes(N-carboxymethyl)valine Daclatasvir (Daclatasvir Impurity A) is the main degradation product of Daclatasvir. |
|
V52686 | N-Acetyl sulfadiazine-d4 | 1219149-66-2 | N-Acetyl sulfadiazine-d4 is the deuterium labelled form of Triton X-45(n=4). |
|
V76309 | NCI-B16 | 802835-01-4 | NCI-B16 is a small RNA binding agent that can inhibit HCV (hepatitis C virus) viral replication. |
|
V18035 | Nesbuvir | 691852-58-1 | Nesbuvir (VB-19796 ; VB19796; HC-V796; HCV796)is a novel and potent NS5B (nonstructural protein 5B) polymerase inhibitorthat has the potential for HCV treatment. |
|
V14696 | NM-107 | 20724-73-6 | NM-107 (2'-C-Methylcytidine; 2'CMeC; 2'-C-MeC; mCyd; 2CMC) is a novel, potent and selective anti-viral agent acting as an inhibitor of the hepatitis C virus (HCV) NS5B polymerase. |
|
V54231 | QDVKFP | 153299-82-2 | PQDVKFP is a synthetic peptide that recognizes the antigenic domain of the HCV (hepatitis C virus) core protein. |
|
V54228 | Pseudane IX (2-Nonylquinolin-4(1H)-one) | 55396-45-7 | Pseudane IX is a compound that can be extracted from the leaves of Ruta angustifolia and has strong anti-HCV (hepatitis C virus) activity with IC50 of 1.4 μg/mL. |
|
V39716 | PSI-353661 (GS-558093) | 1231747-08-2 | PSI-353661 (GS-558093) is a purine nucleotide NS5B polymerase inhibitor that protects against HCV (hepatitis C virus) infection. |
|
V3664 | PSI-6130 | 817204-33-4 | PSI-6130 (R-1656) is a novel, potent and selective inhibitor ofHCV NS5B polymerase whichinhibits HCV replication with a meanIC50of 0.6 μM. |
|
V3614 | PSI-6206 13CD3 | 1256490-42-2 | PSI-6206 13CD3 (RO-2433 13CD3; GS-331007 13CD3; Sofosbuvir metabolite GS-331007 13CD3) is the deuterium labeled form of PSI-6206. |
|
V3612 | PSI-7409 | 1015073-42-3 | PSI-7409 is a novel and active 5-triphosphate metabolite of Sofosbuvir (PSI-7977). |
|
V3613 | PSI-7409 tetrasodium | 1621884-22-7 | PSI-7409 tetrasodium is a novel and active 5-triphosphate metabolite of Sofosbuvir (PSI-7977). |
|
V51777 | Resiquimod-d5 | 2252319-44-9 | deuterium labeled form of Resiquimod |
|
V56211 | Ribavirin-13C5 (ICN-1229-13C5) | 1646818-35-0 | Ribavirin-13C5 is a 13C (carbon 13)-labeled Ribavirin. |
|
V3659 | RO-9187 | 876708-03-1 | RO-9187 is a novel and potent inhibitor ofHCVvirus replication withIC50of 171 nM. |
|
V3155 | Simeprevir sodium | 1241946-89-3 | Simeprevir sodium, the sodium salt of simeprevir (previously known asTMC43), is a competitive, reversible, macrocyclic, noncovalent inhibitor of the hepatitis C virus (HCV) NS3/4A protease. |
|
V35462 | SMCypI C31 | 2649904-85-6 | SMCypIC31 is a non-peptide cyclophilin inhibitor (antagonist) with potent peptidyl-prolyl cis/trans isomerase (PPIase) inhibitory activity (IC50 of 0.1 µM). |
|
V76493 | Sofosbuvir impurity H | Sofosbuvir impurity H is a diastereomer of Sofosbuvir and an impurity of Sofosbuvir. | |
|
V54234 | Sofosbuvir impurity I (sofosbuvir impurity I) | 2164516-85-0 | Sofosbuvir impurity I is a diastereomer of Sofosbuvir and an impurity of Sofosbuvir. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
